Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HERBALIFE LTD. Director's Dealing 2020

Nov 24, 2020

32337_dirs_2020-11-24_a9790526-b2f8-4647-8a21-067961669899.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HERBALIFE NUTRITION LTD. (HLF)
CIK: 0001180262
Period of Report: 2020-11-20

Reporting Person: Tartol John (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-20 Common Stock M 9052 $39.79 Acquired 369938 Direct
2020-11-20 Common Stock F 7479 $48.16 Disposed 362459 Direct
2020-11-23 Common Stock S 55000 $48.83 Disposed 307459 Direct
2020-11-24 Common Stock S 1573 $48.35 Disposed 305886 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-11-20 Stock Appreciation Rights $39.79 M 9052 Disposed 2020-12-19 Common Stock (9052) Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $48.65 to $49.05. The price reported reflects the weighted average sale price of $48.83. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as covering
4,526 shares at an exercise price of $79.58 per share.

F3: The SARs were granted on December 19, 2013. 50% vested on December 19, 2013, 25% vested on January 15, 2014 and the remaining 25% vested on April 15, 2014.